Your fact-checks will appear here
Part the Cloud program for early-phase clinical trials focused on mitochondria, vascular mechanisms, and neuroinflammation.
The short answer: has publicly supported several activities and investments aimed at improving, preserving, or understanding the mind — from recommending books about mindset to funding and backing bra...
–backed initiatives and investments favor a pluralistic, translational approach to Alzheimer’s therapeutics that explicitly includes small molecules and biologics but emphasizes newer mechanisms—mitoc...
has deployed a mix of personal philanthropy and partnership funding to accelerate diagnostics, drug discovery and data-sharing, including a $100 million personal commitment, a $50 million investment i...
has become a major private funder and public advocate in the fight against Alzheimer’s, committing hundreds of millions through donations, targeted grants, and new investment vehicles aimed at early d...